Digital artist Refik Anadol captures data from nature to preserve its memory. Source: McKinsey Using AI and data to make immersive art

A major upheaval reduced demand for office space on a global scale. The question now is, what’s the future of the office? Source: McKinsey The future of the office

Leaders can achieve and sustain the highest levels of operational excellence in the mining sector, despite its cyclical nature. Here’s how. Source: McKinsey Mining for operational excellence

Founder and CEO of Cirkul joins the show to share lessons learned from the company’s business journey. …Read More Source: Knowledge @ Wharton Building a Brand: The Entrepreneurial Lessons Learned on the Road to Cirkul’s Success

In addition to Spain’s economic, cultural, and historical connections to Latin America, its advantages can develop the country into a leading regional cybersecurity powerhouse. Source: McKinsey Europe’s next cybersecurity hub: What makes Spain a leading contender?

As more consumers seek tailored online interactions, companies can turn to AI and generative AI to better scale their ability to personalize experiences. Source: McKinsey Unlocking the next frontier of personalized marketing

Our January obituaries also include a plasma screen inventor, a backpack trendsetter, and a Holocaust survivor who became a five-time Olympic gold medalist. Source: McKinsey A premier crisis management expert, a retail and media giant, and a DIY powerhouse

The role is harder than ever, requiring new habits of mind, body, and spirit. Source: McKinsey The CEO as elite athlete: What business leaders can learn from modern sports

An insider’s look at the annual meeting of the World Economic Forum: The mountaintop was buzzing as leaders confront a world in flux. Source: McKinsey Special episode: Debriefing Davos 2025

Even though the biopharma supply chain is a dynamic and complex part of the pharmaceutical industry, private equity investors can find growth and value creation opportunities. Here’s how. Source: McKinsey From discovery to delivery: Finding an investment edge in biopharma services